Description

Pyrido[2,1-C][1,4]Oxazin-8(1H)-One, 3,4,9,9A-Tetrahydro- is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant commercial interest for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by research institutions and manufacturers in the pharmaceutical and biotechnology sectors engaged in drug discovery and development programs.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of complex drug candidates, particularly those targeting central nervous system (CNS) disorders.
• Organic Synthesis Building Block: Used in research-scale and pilot-scale organic chemistry for constructing fused polycyclic systems with potential biological activity.
• Medicinal Chemistry Research: Serves as a scaffold for structure-activity relationship (SAR) studies in the development of new therapeutic agents.
• Contract Manufacturing (CMO): Supplied to contract development and manufacturing organizations (CDMOs) for cGMP production of clinical trial materials.
• Academic Research: Utilized in university and institutional labs for methodological development and exploring new chemical spaces in heterocyclic chemistry.

Basic Information

Product Name	Pyrido[2,1-C][1,4]Oxazin-8(1H)-One, 3,4,9,9A-Tetrahydro-
CAS No.	181956-63-8
Molecular Formula	C7H9NO2
Molecular Weight	139.15 g/mol
Synonyms	3,4,9,9a-Tetrahydro-1H-pyrido[2,1-c][1,4]oxazin-8-one; 1H-Pyrido[2,1-c][1,4]oxazin-8-one, 3,4,9,9a-tetrahydro-; Tetrahydro-pyrido-oxazinone; CAS 181956-63-8
EINECS	Contact for details

Quality Control

Our production of Pyrido[2,1-C][1,4]Oxazin-8(1H)-One, 3,4,9,9A-Tetrahydro- adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS). We provide full traceability and a detailed Certificate of Analysis (COA) with every shipment, ensuring compliance with the specifications required for advanced pharmaceutical R&D and cGMP manufacturing.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials such as strong oxidizing agents. For long-term storage, consider an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.